Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Polycystic Ovary Syndrome
- Reproductive Medicine
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 35 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03059173
- Collaborators
- Ministry of Health, France
- Investigators
- Principal Investigator: Goeffrey Robin, MD University Hospital, Lille